BACKGROUND: Follow-up endoscopy after total gastrectomy for gastric cancer is commonly performed without there being any definite evidence of clinical relevance. Therefore, we investigated the role of the upper endoscopic examinations after total gastrectomy for gastric cancer. METHODS: The medical records of 212 early gastric cancer (EGC) patients and 622 advanced gastric cancer (AGC) patients who underwent follow-up endoscopic examination after total gastrectomy between 1994 and 2001 were reviewed. RESULTS: Two of 212 EGC patients and 233 of 622 AGC patients revealed tumour recurrence at all sites. All the endoscopically accessible local tumour recurrences (n=24) were found in the AGC group. Anastomosis site stenosis was detected in 72 of 834 patients. CONCLUSION: Follow-up endoscopy after total gastrectomy for gastric cancer is useful in detecting complications and tumour recurrence. However, this procedure has a limited role in the clinical management and overall survival for patients with recurrent gastric adenocarcinoma.
BACKGROUND: Follow-up endoscopy after total gastrectomy for gastric cancer is commonly performed without there being any definite evidence of clinical relevance. Therefore, we investigated the role of the upper endoscopic examinations after total gastrectomy for gastric cancer. METHODS: The medical records of 212 early gastric cancer (EGC) patients and 622 advanced gastric cancer (AGC) patients who underwent follow-up endoscopic examination after total gastrectomy between 1994 and 2001 were reviewed. RESULTS: Two of 212 EGC patients and 233 of 622 AGC patients revealed tumour recurrence at all sites. All the endoscopically accessible local tumour recurrences (n=24) were found in the AGC group. Anastomosis site stenosis was detected in 72 of 834 patients. CONCLUSION: Follow-up endoscopy after total gastrectomy for gastric cancer is useful in detecting complications and tumour recurrence. However, this procedure has a limited role in the clinical management and overall survival for patients with recurrent gastric adenocarcinoma.
Authors: Leila Sisic; Moritz J Strowitzki; Susanne Blank; Henrik Nienhueser; Sara Dorr; Georg Martin Haag; Dirk Jäger; Katja Ott; Markus W Büchler; Alexis Ulrich; Thomas Schmidt Journal: Gastric Cancer Date: 2017-07-24 Impact factor: 7.370
Authors: P S Adusumilli; D P Eisenberg; B M Stiles; K J Hendershott; S F Stanziale; M-K Chan; M Hezel; R Huq; V W Rusch; Y Fong Journal: Surg Endosc Date: 2006-01-30 Impact factor: 4.584
Authors: Cynthia Villarreal-Garza; Miriam Rojas-Flores; Andrea Castro-Sánchez; Antonio R Villa; Luis García-Aceituno; Eucario León-Rodríguez Journal: Med Oncol Date: 2010-06-02 Impact factor: 3.064
Authors: Chan Gyoo Kim; Il Ju Choi; Jong Yeul Lee; Soo-Jeong Cho; Jun Ho Lee; Keun Won Ryu; Sook Ryun Park; Jae-Moon Bae; Young-Woo Kim Journal: Surg Endosc Date: 2008-12-06 Impact factor: 4.584
Authors: Sung Jae Park; Young Soo Park; In Sub Jung; Hyuk Yoon; Cheol Min Shin; Sang-Hoon Ahn; Do Joong Park; Hyung Ho Kim; Nayoung Kim; Dong Ho Lee Journal: PLoS One Date: 2018-06-01 Impact factor: 3.240
Authors: Sing Yu Moorcraft; Elisa Fontana; David Cunningham; Clare Peckitt; Tom Waddell; Elizabeth C Smyth; William Allum; Jeremy Thompson; Sheela Rao; David Watkins; Naureen Starling; Ian Chau Journal: BMC Cancer Date: 2016-02-17 Impact factor: 4.430